Novo Nordisk A/S (NYSE: NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a multiyear anticompetitive scheme designed to delay generic competition. • What’s ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The calls came over the span of a single month in 2004, ...

The study reveals how Balanophora plants function despite abandoning photosynthesis and, in some species, sexual reproduction. Their plastid genomes shrank dramatically in a shared ancestor, yet the ...

This paper provides a parsimonious yet tractable approach to evaluating maximum sustainable debt across countries and over time within the p-theory framework developed by Jiang et al. (2024). By ...

Beverly is a writer, editor, and paralegal specializing in personal finance and tax law. She covers personal financial and legal topics, as well as tax breaks, tax preparation software, and tax law ...

Novo Nordisk said second-quarter sales of its blockbuster Wegovy weight-loss drug soared 67% on year, despite millions of U.S. patients using generic unbranded versions of the drug. The Danish company ...

We all lose our gadgets every once in a while. Finding them isn’t always straightforward, especially if they have been stolen or left behind in a different place. Likewise, if it’s nestled between the ...

For this week’s Open Questions column, Dhruv Khullar is filling in for Joshua Rothman. When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started ...

AI hype is everywhere, but investors must distinguish between empty buzz and companies with real, data-driven AI advantages. I highlight Five9, Intuit, Hello Group, Getty Images, and Planet Labs as ...